Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
  • Rating
    2
  • Minimum Investment
    ₹5000
  • NAV (Net Asset Value)
    ₹N/A
  • AUM (Fund size)
    ₹9480 Cr
  • Created on
    6 June 2004
Fund Ranking
#17
/ 17 in Sectoral-Pharma
Risk Level

Very High

Loading...
Returns
Trailing Return
Rolling Return
  • 6 Month
    13.7%
  • 1 Year
    9.7%
  • 3 Year (CAGR)
    16.8%
  • All Time (CAGR)
    19.7%
Category Return
  • 6 Month
    18.4%
  • 1 Year
    13.5%
  • 3 Year (CAGR)
    20.1%
  • All Time (CAGR)
    16.9%
Asset Allocation
  • Equity
    98.0%
  • Other
    2.0%
Top 5 Holdings
Top 5 Sectors
  • Apollo Hospitals Enterprise
    5.15%
  • Astrazeneca Pharma India
    0.46%
  • Aurobindo Pharma
    1.63%
  • Cipla
    6.09%
  • Dr. Reddy's Laboratories
    4.93%
Fund Information
  • Expense Ratio
    1.84%
  • Exit Load
    Exit load of 1% if redeemed within 1 month.
  • Lock-In Period
    No Lock-In

Managed By

Sailesh Raj Bhan
March 2005 - Present
Divya Dutt Sharma
Sep 2025 - Present
Lokesh Maru
Sep 2025 - Present
Kinjal Desai
March 2026 - Present
Amber Singhania
March 2026 - Present
Risk & Return Ratio
  • Sharpe Ratio
    0.73
  • Standard Deviation
    15.06
  • Alpha
    -2.43
  • Beta
    0.89